icotec Announces FDA clearance for Spinal Infection Indication with BlackArmor® Implants

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

icotec-Medical-FDA

More Like This

PR Newswire associated0

icotec ag raises $30m in growth financing from MVM Partners

Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage

PR Newswire associated0

icotec Medical Appoints Christoph Eigenmann as New US CEO and Promotes Carter Lonsberry to Executive Chairman of the Board

PR Newswire associated0

Spineart Receives 510(k) Clearance for SCARLET® AC-Ti Anterior Cervical Cage

Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage

Inside information: Bioretec updates its financial targets

Inside Information: Update for Bioretec's RemeOs™ Trauma Screw European Marketing Authorization

Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures